Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California. Show more

1350 OLD BAYSHORE HIGHWAY, BURLINGAME, CA, UNITED STATES, 94010, Burlingame, CA, 94010, USA

https://www.inva.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

1.499B

52 Wk Range

$16.52 - $25.14

Previous Close

$20.81

Open

$21.00

Volume

527,238

Day Range

$20.59 - $21.01

Enterprise Value

1.185B

Cash

570.4M

Avg Qtr Burn

N/A

Insider Ownership

1.01%

Institutional Own.

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NUZOLVENCE® (zoliflodacin) Details Uncomplicated Gonorrhoea	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Xerava (eravacycline) Details Intra-abdominal infections	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Zevtera/Ceftobiprole (Ceftobiprole) (Cephalosporin Antibiotic) Details Staphylococcus Aureus Bacteremia, Acute Bacterial Skin And Skin Structure Infections, And Community-Acquired Bacterial Pneumonia	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
XACDURO Details Acinetobacter infection	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Giapreza (angiotensin II) Details Septic shock	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.